ENCEFA is a biotech company that develops modulate CD38 drugs for age-related diseases.
ENCEFA has raised $250K in total funding. The most recent round was Seed. The last funding was announced in December 2021.
ENCEFA's investors include Newchip Accelerator.
ENCEFA is headquartered in La Maison, France.
ENCEFA is a biotech company that develops modulate CD38 drugs for age-related diseases.
ENCEFA is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ENCEFA — Funding & Investors." VCBacked, December 30, 2021, https://www.vcbacked.co/company/encefa. Accessed August 18, 2026.
VCBacked. (2021). ENCEFA — Funding & Investors. Retrieved August 18, 2026, from https://www.vcbacked.co/company/encefa
{{cite web |title=ENCEFA — Funding & Investors |url=https://www.vcbacked.co/company/encefa |website=VCBacked |access-date=August 18, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated